OHSU News

This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.

New questions about the tradeoffs in ‘accelerated’ cancer drug studies

New questions about the tradeoffs in ‘accelerated’ cancer drug studies

Cancer clinical trials that use surrogate endpoints end up saving relatively little time, a new study finds.